Scarica l'app Stockscreener
3.07
5.25%
-0.17
Dopo l'orario di chiusura:
3.07
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.24
Aprire:
$3.2
Volume 24 ore:
54,805
Relative Volume:
0.33
Capitalizzazione di mercato:
$45.92M
Reddito:
$44.52M
Utile/perdita netta:
$-2.86M
Rapporto P/E:
-16.06
EPS:
-0.1912
Flusso di cassa netto:
$4.75M
1 W Prestazione:
+8.48%
1M Prestazione:
-37.60%
6M Prestazione:
-0.65%
1 anno Prestazione:
-25.67%
Intervallo 1D:
$3.03
$3.935
Intervallo di 1 settimana:
$2.84
$3.935
Portata 52W:
$1.85
$6.265
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Nome
Cumberland Pharmaceuticals Inc
Settore
Telefono
615-255-0068
Indirizzo
1600 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
3.07 | 45.92M | 44.52M | -2.86M | 4.75M | -0.1912 |
TAK
Takeda Pharmaceutical Co Adr
|
17.91 | 56.58B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
113.35 | 47.85B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.80 | 43.75B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.74 | 33.47B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
522.83 | 22.91B | 3.18B | 1.33B | 1.04B | 27.90 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2012-11-12 | Reiterato | UBS | Neutral |
| 2011-02-01 | Reiterato | UBS | Neutral |
| 2010-12-16 | Downgrade | UBS | Buy → Neutral |
| 2010-08-17 | Downgrade | Jefferies | Buy → Hold |
| 2010-08-17 | Reiterato | Morgan Joseph | Buy |
| 2010-08-17 | Reiterato | UBS | Buy |
| 2010-05-14 | Reiterato | Morgan Joseph | Buy |
Mostra tutto
Cumberland Pharmaceuticals Inc Borsa (CPIX) Ultime notizie
Risks Report: Is Cumberland Pharmaceuticals Inc stock a top performer YTD2026 EndofYear Setup & Growth Focused Investment Plans - baoquankhu1.vn
CPIX Technical Analysis & Stock Price Forecast - Intellectia AI
Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma - Barchart.com
Asthma Market: High-Growth Opportunities for Investors to 2034 - openPR.com
Aug Catalysts: Why is Cumberland Pharmaceuticals Inc stock going up2026 Opening Moves & Weekly Chart Analysis and Guides - baoquankhu1.vn
EV Market: Is Cumberland Pharmaceuticals Inc backed by strong institutional buyingMarket Growth Summary & Real-Time Stock Price Movement Reports - baoquankhu1.vn
CPIX SEC FilingsCumberland Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Director at Cumberland Pharmaceuticals (CPIX) receives 1,800-share stock grant - Stock Titan
Cumberland Pharmaceuticals (CPIX) director receives 1,800-share stock grant - Stock Titan
Cumberland Pharmaceuticals (CPIX) director granted 1,800 shares in Form 4 filing - Stock Titan
[Form 4] CUMBERLAND PHARMACEUTICALS INC Insider Trading Activity - Stock Titan
Cumberland (CPIX) director Caroline Young receives 1,800-share stock grant - Stock Titan
Cumberland (CPIX) VP awarded 3,000 stock options at $2.80 strike - Stock Titan
Cumberland (CPIX) VP awarded options to buy 3,000 shares at $2.80 - Stock Titan
Cumberland Pharmaceuticals (CPIX) CFO granted 3,000 stock options - Stock Titan
Cumberland Pharmaceuticals (CPIX) CEO granted 100,000 stock options - Stock Titan
Retail Trends: What makes Cumberland Pharmaceuticals Inc stock attractive todayIndex Update & Precise Swing Trade Alerts - baoquankhu1.vn
Cumberland (NASDAQ: CPIX) CEO A.J. Kazimi reports routine tax-withholding share disposition - Stock Titan
Cumberland targets double-digit revenue growth in 2026 as Talicia and Vibativ fuel expansion - MSN
Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting - PR Newswire
New site spotlights chemo nausea patch that helps for five days - Stock Titan
Cumberland Pharmaceuticals Stock Rating Upgraded - National Today
Aug Macro: What is the dividend yield of Cumberland Pharmaceuticals Inc2026 Summary & Community Verified Trade Signals - baoquankhu1.vn
[ARS] CUMBERLAND PHARMACEUTICALS INC SEC Filing - Stock Titan
Trend Report: Can Cumberland Pharmaceuticals Inc beat the S P 500Trade Exit Summary & High Conviction Buy Zone Picks - baoquankhu1.vn
Dilated Cardiomyopathy Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Bristol Myers Squibb, Berlin Cures, Cumberland Pharma, Vericel Corp, Corimmun GmbH, Pfizer, Constant Therapeut - Barchart.com
Cumberland Q4 Loss Narrows Y/Y as Talicia Launch Boosts Sales - The Globe and Mail
Cumberland Pharmaceuticals (NASDAQ: CPIX) details 2026 director, pay and auditor votes - Stock Titan
Cumberland Pharmaceuticals Inc. Business Overview, Product Portfolio, Growth Strategy, and International Partnerships 2025 - Minichart
Cumberland Pharmaceuticals 2025 10-K — Revenue $44.5M, Net loss $2.9M - TradingView
Swing Trade: What is the dividend yield of Cumberland Pharmaceuticals IncPortfolio Risk Summary & Low Risk High Reward Trade Ideas - baoquankhu1.vn
How resilient is Cumberland Pharmaceuticals Inc. stock in market downturns2026 Rallies & Low Volatility Stock Recommendations - Naître et grandir
Risk Recap: Will Cumberland Pharmaceuticals Inc announce a stock splitJuly 2025 Catalysts & Short-Term High Return Ideas - baoquankhu1.vn
Aug Highlights: Can Cumberland Pharmaceuticals Inc reach all time highs this year - baoquankhu1.vn
Momentum Shift: Is Cumberland Pharmaceuticals Inc in a bullish channelTrade Entry Summary & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Pale Fire Capital Bets Big on Healthcare With a 2.07 Million Share Baxter International (BAX) Investment - AOL.com
1 Basically Unknown Stock That Could Turn Cancer‑Imaging Breakthroughs Into Generational Wealth - AOL.com
Phibro Animal Health President and CEO Sells 72k Shares After Strong Q2 2026 Performance - AOL.com
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing - AOL.com
147M H. pylori patients set stage for new stomach infection drugs - Stock Titan
Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection - AOL.com
CPIX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cumberland Pharmaceuticals Reports 31% Q4 2025 Revenue Growth, Expands Internationally, and Achieves Key Clinical and Financial Milestones - Minichart
Cumberland (CPIX) Q4 2025 Earnings Call Transcript - AOL.com
Cumberland: Fourth Quarter Financial Results Overview - Bitget
Earnings call transcript: Cumberland Pharmaceuticals Q4 2025 sees revenue surge - Investing.com
Cumberland Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat
Cumberland: Q4 Earnings Snapshot - GreenevilleSun.com
Cumberland Pharmaceuticals 2025 revenue rises - TradingView
CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH - PR Newswire
Cumberland Pharmaceuticals Inc (CPIX) Q4 2025 Earnings Call Highlights: Revenue Surge and ... By GuruFocus - Investing.com Canada
Cumberland Pharmaceuticals Inc Azioni (CPIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.11%
1.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):